Paul W. Hawran, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 5,000 shares at $4.65 ($23K) on 2010-05-24, disclosed to the SEC on 2010-05-24.
Open-market purchase of $23k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYTX | BUY | 2009-11-25 | $25K | — | Filing → |
| CYTX | BUY | 2009-11-24 | $24K | — | Filing → |
| CYTX | BUY | 2009-11-18 | $85K | — | Filing → |